The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease

Leopoldo Raij

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The current understanding of the interrelationships among hemodynamic, hormonal, and metabolic factors in the pathophysiology of renal disease remains incomplete. In the kidney, the renin-angiotensin system (RAS) plays an important role in all three of these physiologic pathways. There is no doubt that hypertension and diabetes are major risk factors for the progression of renal disease and that interruption of the RAS is renoprotective. In particular, the balance of interactions between angiotensin II and nitric oxide is a key factor in determining whether injury or protection of target organs ensues. Experimental studies suggest a novel link between hemodynamic and metabolic factors that may cooperate to induce progressive glomerular injury in conditions characterized by glomerular hypertension. Emerging data from experimental and clinical studies may lead to improvements in therapeutic efforts to prevent or slow the progression of renal disease.

Original languageEnglish
JournalAmerican Journal of Hypertension
Volume18
Issue number4 SUPPL.
DOIs
StatePublished - Apr 1 2005

Fingerprint

Renin-Angiotensin System
Kidney
Disease Progression
Hemodynamics
Hypertension
Wounds and Injuries
Angiotensin II
Nitric Oxide
Therapeutics

Keywords

  • Angiotensin II
  • Angiotensin receptor blockers
  • Angiotensin-converting enzyme inhibitors
  • Calcium channel blockers
  • Glucose transporters
  • Nitric oxide
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. / Raij, Leopoldo.

In: American Journal of Hypertension, Vol. 18, No. 4 SUPPL., 01.04.2005.

Research output: Contribution to journalArticle

@article{ea877601c280483499a99036a1a9035a,
title = "The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease",
abstract = "The current understanding of the interrelationships among hemodynamic, hormonal, and metabolic factors in the pathophysiology of renal disease remains incomplete. In the kidney, the renin-angiotensin system (RAS) plays an important role in all three of these physiologic pathways. There is no doubt that hypertension and diabetes are major risk factors for the progression of renal disease and that interruption of the RAS is renoprotective. In particular, the balance of interactions between angiotensin II and nitric oxide is a key factor in determining whether injury or protection of target organs ensues. Experimental studies suggest a novel link between hemodynamic and metabolic factors that may cooperate to induce progressive glomerular injury in conditions characterized by glomerular hypertension. Emerging data from experimental and clinical studies may lead to improvements in therapeutic efforts to prevent or slow the progression of renal disease.",
keywords = "Angiotensin II, Angiotensin receptor blockers, Angiotensin-converting enzyme inhibitors, Calcium channel blockers, Glucose transporters, Nitric oxide, Renin-angiotensin system",
author = "Leopoldo Raij",
year = "2005",
month = "4",
day = "1",
doi = "10.1016/j.amjhyper.2004.11.040",
language = "English",
volume = "18",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "4 SUPPL.",

}

TY - JOUR

T1 - The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease

AU - Raij, Leopoldo

PY - 2005/4/1

Y1 - 2005/4/1

N2 - The current understanding of the interrelationships among hemodynamic, hormonal, and metabolic factors in the pathophysiology of renal disease remains incomplete. In the kidney, the renin-angiotensin system (RAS) plays an important role in all three of these physiologic pathways. There is no doubt that hypertension and diabetes are major risk factors for the progression of renal disease and that interruption of the RAS is renoprotective. In particular, the balance of interactions between angiotensin II and nitric oxide is a key factor in determining whether injury or protection of target organs ensues. Experimental studies suggest a novel link between hemodynamic and metabolic factors that may cooperate to induce progressive glomerular injury in conditions characterized by glomerular hypertension. Emerging data from experimental and clinical studies may lead to improvements in therapeutic efforts to prevent or slow the progression of renal disease.

AB - The current understanding of the interrelationships among hemodynamic, hormonal, and metabolic factors in the pathophysiology of renal disease remains incomplete. In the kidney, the renin-angiotensin system (RAS) plays an important role in all three of these physiologic pathways. There is no doubt that hypertension and diabetes are major risk factors for the progression of renal disease and that interruption of the RAS is renoprotective. In particular, the balance of interactions between angiotensin II and nitric oxide is a key factor in determining whether injury or protection of target organs ensues. Experimental studies suggest a novel link between hemodynamic and metabolic factors that may cooperate to induce progressive glomerular injury in conditions characterized by glomerular hypertension. Emerging data from experimental and clinical studies may lead to improvements in therapeutic efforts to prevent or slow the progression of renal disease.

KW - Angiotensin II

KW - Angiotensin receptor blockers

KW - Angiotensin-converting enzyme inhibitors

KW - Calcium channel blockers

KW - Glucose transporters

KW - Nitric oxide

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=17444427737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17444427737&partnerID=8YFLogxK

U2 - 10.1016/j.amjhyper.2004.11.040

DO - 10.1016/j.amjhyper.2004.11.040

M3 - Article

C2 - 15837551

AN - SCOPUS:17444427737

VL - 18

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 4 SUPPL.

ER -